Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model

Immunology

Volumn 128, Issue 1, 2009, Pages 123-133

  Marquina Castillo, Brenda ^a   García García, Lourdes ^b   Ponce De León, Alfredo ^a   Jimenez Corona, Maria Eugenia ^b   Bobadilla Del Valle, Miriam ^a   Cano Arellano, Bulmaro ^b   Canizales Quintero, Sergio ^b   Martinez Gamboa, Areli ^a   Kato Maeda, Midori ^c   Robertson, Brian ^d   Young, Douglas ^d   Small, Peter ^e   Schoolnik, Gary ^f   Sifuentes Osornio, Jose ^a   Hernandez Pando, Rogelio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

Immunogenicity; Immunopathology; Molecular epidemiology; Murine model; Transmission; Tuberculosis

Indexed keywords

CYTOKINE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUBERCULIN; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE MODEL; FEMALE; HUMAN; INNATE IMMUNITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ANIMALS; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 68249103130     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.03004.x     Document Type: Article

References (31)

1. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992 257 : 1055 64.
2. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997 119 : 183 201.
3. Gutacker MM, Smoot JC, Migliaccio CA et al. Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 2002 162 : 1533 43.
4. Nardell EA. Environmental control of tuberculosis. Med Clin North Am 1993 77 : 1315 34.
5. Manca C, Tsenova L, Barry CE. 3rd. et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999 162 : 6740 6.
6. Manca C, Tsenova L, Bergtold A et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\beta. Proc Natl Acad Sci USA 2001 98 : 5752 7.
7. Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, Roholl P, Arend SM, Van Soolingen D. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB\c mouse model. Clin Exp Immunol 2004 137 : 460 8.
8. Fleischmann RD, Alland D, Eisen JA et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 2002 184 : 5479 90.
9. Lopez B, Aguilar D, Orozco H et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003 133 : 30 7.
10. Malik AN, Godfrey-Faussett P. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis 2005 5 : 174 83.
11. Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J, Madrid-Marina V. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 1997 90 : 607 17.
12. Hernandez-Pando R, Orozcoe H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996 89 : 26 33.
13. Hernandez-Pando R, Pavon L, Arriaga K, Orozco H, Madrid-Marina V, Rook G. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 1997 65 : 3317 27.
14. Infante E, Aguilar LD, Gicquel B, Pando RH. Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant. Clin Exp Immunol 2005 141 : 21 8.
15. Lipsitch M, Moxon ER. Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol 1997 5 : 31 7.
16. Garcia-Garcia M, Palacios-Martinez M, Ponce-de-Leon A et al. The role of core groups in transmitting Mycobacterium tuberculosis in a high prevalence community in Southern Mexico. Int J Tuberc Lung Dis 2000 4 : 12 7.
17. Garcia-Garcia ML, Jimenez-Corona ME, Ponce-de-Leon A et al. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico. Int J Tuberc Lung Dis 2000 4 : S168 70.
18. Garcia-Garcia ML, Small PM, Garcia-Sancho C et al. Tuberculosis epidemiology and control in Veracruz, Mexico. Int J Epidemiol 1999 28 : 135 40.
19. Jimenez-Corona ME, Garcia-Garcia L, DeRiemer K et al. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax 2006 61 : 348 53.
20. DeRiemer K, Garcia-Garcia L, Bobadilla-del-Valle M, Palacios-Martinez M, Martinez-Gamboa A, Small PM, Sifuentes-Osornio J, Ponce-de-Leon A. Does DOTS work in populations with drug-resistant tuberculosis? Lancet 2005 365 : 1239 45.
21. Garcia-Garcia Mde L, Ponce-De-Leon A, Garcia-Sancho MC et al. Tuberculosis-related deaths within a well-functioning DOTS control program. Emerg Infect Dis 2002 8 : 1327 33.
22. Secretaria de Salud. Norma Oficial Mexicana NOM-006-ssa2-1993, para la prevención y control de la tuberculosis en la atención primaria a la salud. Río Amazonas, México : Diario Oficial de la Federación, 1995 : 20 9.
23. Anonymous. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995 44 : 19 34.
24. Jarnagin JL, Luchsinger DW. The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria. Stain Technol 1980 55 : 253 8.
25. Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch Intern Med 2000 160 : 630 6.
26. Ewald P. Evolution of Infectious Disease. New York : Oxford University Press, 1994.
27. Kaushal D, Schroeder BG, Tyagi S et al. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci USA 2002 99 : 8330 5.
28. Ottenhoff TH, Verreck FA, Hoeve MA, Van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis (Edinb) 2005 85 : 53 64.
29. Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000 181 : 385 9.
30. van Crevel R, Karyadi E, Preyers F, Leenders M, Kullberg BJ, Nelwan RH, van der Meer JW. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000 181 : 1194 7.
31. Rivas-Santiago B, Sada E, Tsutsumi V, Aguilar-Leon D, Contreras JL, Hernandez-Pando R. Beta-defensin gene expression during the course of experimental tuberculosis infection. J Infect Dis 2006 194 : 697 701.